Marjolein B. Aerts

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy

Tainá M. Marques, H. Bea Kuiperij, Ilona B. Bruinsma et al. · Molecular Neurobiology · 2016 · 135 citations · Full text

Multiple System Atrophy, Neurological Progress, Neurochemical Biomarkers +20

CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls

Megan K. Herbert, Jorine M. Eeftens, Marjolein B. Aerts et al. · Parkinsonism & Related Disorders · 2013 · 86 citations

Csf Levels, Neurodegenerative Diseases, Autoimmune Disease +9

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders

Megan K. Herbert, Marjolein B. Aerts, Marijke Beenes et al. · Frontiers in Neurology · 2015 · 76 citations · Full text

Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism

Frederick J. A. Meijer, Anouke van Rumund, Anil M. Tuladhar et al. · Neuroradiology · 2015 · 43 citations · Full text

CSF Tau, Aβ42, and MHPG Differentiate Dementia with Lewy Bodies from Alzheimer's Disease

Marjolein B. Aerts, Rianne A.J. Esselink, J.A.H.R. Claassen et al. · Journal of Alzheimer s Disease · 2011 · 39 citations · Full text